Ignite Creation Date:
2024-05-06 @ 3:16 AM
Last Modification Date:
2024-10-26 @ 11:30 AM
Study NCT ID:
NCT02244502
Status:
UNKNOWN
Last Update Posted:
2016-09-21
First Post:
2014-09-15
Brief Title:
Safety Feasibility and Effect of TTFields 200 kHz Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma INNOVATE
Sponsor:
NovoCure Ltd
Organization:
NovoCure Ltd
Organization Data
Organization:
NovoCure Ltd
Class:
INDUSTRY
Study ID:
EF-22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovoCure Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None